In a report issued on July 13, Deane Dray from RBC Capital maintained a Buy rating on Danaher (DHR – Research Report), with a price target of $301.00. The company’s shares closed last Thursday at $248.06, close to its 52-week low of $233.71.
According to TipRanks.com, Dray is a 4-star analyst with an average return of 6.8% and a 46.1% success rate. Dray covers the Industrial Goods sector, focusing on stocks such as Atkore International Group, Evoqua Water Technologies, and Emerson Electric Company.
Currently, the analyst consensus on Danaher is a Strong Buy with an average price target of $311.67, which is a 25.6% upside from current levels. In a report issued on July 5, Evercore ISI also maintained a Buy rating on the stock with a $280.00 price target.
Based on Danaher’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $7.69 billion and net profit of $1.73 billion. In comparison, last year the company earned revenue of $6.86 billion and had a net profit of $1.7 billion.
Based on the recent corporate insider activity of 65 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Founded in 1969 and headquartered in Washington, DC, Danaher Corp. engages in manufacturing, designing and marketing of professional, medical, industrial and commercial products and services. The company operates through three segments, including Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Read More on DHR: